{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:18:51Z","timestamp":1788985131552,"version":"build-2803163510"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41577-025-01162-5","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:01:30Z","timestamp":1745395290000},"page":"649-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Vaccination in pregnancy to protect the newborn"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5654-5083","authenticated-orcid":false,"given":"Victoria","family":"Male","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1523-2368","authenticated-orcid":false,"given":"Christine E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"1162_CR1","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","volume":"388","author":"L Liu","year":"2016","unstructured":"Liu, L. et al. Global, regional, and national causes of under-5 mortality in 2000\u201315: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 388, 3027\u20133035 (2016).","journal-title":"Lancet"},{"key":"1162_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/archdischild-2023-326625","volume":"110","author":"O Akeju","year":"2025","unstructured":"Akeju, O., Lees, E. A., Amirthalingam, G., Ramsay, M. E. & Pollard, A. J. Changes to the UK childhood immunisation schedule. Arch. Dis. Child 110, 180\u2013187 (2025).","journal-title":"Arch. Dis. Child"},{"key":"1162_CR3","first-page":"CD002959","volume":"2015","author":"V Demicheli","year":"2015","unstructured":"Demicheli, V., Barale, A. & Rivetti, A. Vaccines for women for preventing neonatal tetanus. Cochrane Database Syst. Rev. 2015, CD002959 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1162_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4824-3","volume":"20","author":"S Vygen-Bonnet","year":"2020","unstructured":"Vygen-Bonnet, S. et al. Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review. BMC Infect. Dis. 20, 136 (2020). This systematic review and meta-analysis synthesises the evidence on the safety of pertussis vaccination during pregnancy, and its effectiveness at preventing pertussis in newborns.","journal-title":"BMC Infect. Dis."},{"key":"1162_CR5","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","volume":"384","author":"G Amirthalingam","year":"2014","unstructured":"Amirthalingam, G. et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 384, 1521\u20131528 (2014).","journal-title":"Lancet"},{"key":"1162_CR6","first-page":"CD001269","volume":"2","author":"V Demicheli","year":"2018","unstructured":"Demicheli, V., Jefferson, T., Ferroni, E., Rivetti, A. & Di Pietrantonj, C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst. Rev. 2, CD001269 (2018). This systematic review and meta-analysis synthesises the evidence on the safety and effectiveness of influenza vaccination during pregnancy, and its effectiveness at protecting newborns.","journal-title":"Cochrane Database Syst. Rev."},{"key":"1162_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S2213-2600(19)30479-5","volume":"8","author":"SB Omer","year":"2020","unstructured":"Omer, S. B. et al. Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials. Lancet Respir. Med. 8, 597\u2013608 (2020). This pooled analysis synthesises safety and efficacy outcomes of three recent randomised controlled trials of influenza vaccination during pregnancy, for protection of the newborn.","journal-title":"Lancet Respir. Med."},{"key":"1162_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-014247","volume":"9","author":"S Fern\u00e1ndez-Garc\u00eda","year":"2024","unstructured":"Fern\u00e1ndez-Garc\u00eda, S. et al. Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysis. BMJ Glob. Health 9, e014247 (2024). This systematic review and meta-analysis synthesises the evidence on the safety of COVID-19 vaccination during pregnancy, and its effectiveness at preventing COVID-19 during pregnancy and in newborns.","journal-title":"BMJ Glob. Health"},{"key":"1162_CR9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","volume":"388","author":"B Kampmann","year":"2023","unstructured":"Kampmann, B. et al. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N. Engl. J. Med. 388, 1451\u20131464 (2023). This paper reports on safety and efficacy outcomes from the pivotal trial of the recently approved RSV vaccine, for use in pregnancy to prevent RSV in newborns.","journal-title":"N. Engl. J. Med."},{"key":"1162_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1126\/science.abk2189","volume":"376","author":"P Brodin","year":"2022","unstructured":"Brodin, P. Immune-microbe interactions early in life: a determinant of health and disease long term. Science 376, 945\u2013950 (2022).","journal-title":"Science"},{"key":"1162_CR11","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jcpa.2007.04.004","volume":"137","author":"C-A Siegrist","year":"2007","unstructured":"Siegrist, C.-A. The challenges of vaccine responses in early life: selected examples. J. Comp. Pathol. 137, S4\u2013S9 (2007).","journal-title":"J. Comp. Pathol."},{"key":"1162_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","volume":"63","author":"G Mor","year":"2010","unstructured":"Mor, G. & Cardenas, I. The immune system in pregnancy: a unique complexity. Am. J. Reprod. Immunol. 63, 425\u2013433 (2010).","journal-title":"Am. J. Reprod. Immunol."},{"key":"1162_CR13","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1016\/j.vaccine.2015.06.108","volume":"33","author":"K Huygen","year":"2015","unstructured":"Huygen, K., Cabor\u00e9, R. N., Maertens, K., Van Damme, P. & Leuridan, E. Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women. Vaccine 33, 4117\u20134123 (2015).","journal-title":"Vaccine"},{"key":"1162_CR14","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1001\/jama.2014.3633","volume":"311","author":"FM Munoz","year":"2014","unstructured":"Munoz, F. M. et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 311, 1760\u20131769 (2014).","journal-title":"JAMA"},{"key":"1162_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/vaccines9060637","volume":"9","author":"V Peer","year":"2021","unstructured":"Peer, V., Muhsen, K., Betser, M. & Green, M. S. Antibody response to pertussis vaccination in pregnant and non-pregnant women \u2014 the role of sex hormones. Vaccines 9, 637 (2021).","journal-title":"Vaccines"},{"key":"1162_CR16","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.1016\/j.vaccine.2018.07.012","volume":"36","author":"KB Fortner","year":"2018","unstructured":"Fortner, K. B. et al. Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women. Vaccine 36, 6354\u20136360 (2018).","journal-title":"Vaccine"},{"key":"1162_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2015.00289","volume":"6","author":"AW Kay","year":"2015","unstructured":"Kay, A. W. & Blish, C. A. Immunogenicity and clinical efficacy of influenza vaccination in pregnancy. Front. Immunol. 6, 289 (2015).","journal-title":"Front. Immunol."},{"key":"1162_CR18","doi-asserted-by":"publisher","first-page":"303.e1","DOI":"10.1016\/j.ajog.2021.03.023","volume":"225","author":"KJ Gray","year":"2021","unstructured":"Gray, K. J. et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am. J. Obstet. Gynecol. 225, 303.e1\u2013303.e17 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1162_CR19","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.2021.7563","volume":"325","author":"A-RY Collier","year":"2021","unstructured":"Collier, A.-R. Y. et al. Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. JAMA 325, 2370\u20132380 (2021).","journal-title":"JAMA"},{"key":"1162_CR20","doi-asserted-by":"publisher","first-page":"68.e1","DOI":"10.1016\/j.ajog.2022.07.014","volume":"228","author":"C Atyeo","year":"2023","unstructured":"Atyeo, C. et al. COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women. Am. J. Obstet. Gynecol. 228, 68.e1\u201368.e12 (2023).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1162_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abi8631","volume":"13","author":"C Atyeo","year":"2021","unstructured":"Atyeo, C. et al. COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women. Sci. Transl. Med. 13, eabi8631 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1162_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31169-8","volume":"13","author":"CG Atyeo","year":"2022","unstructured":"Atyeo, C. G. et al. Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms. Nat. Commun. 13, 3571 (2022).","journal-title":"Nat. Commun."},{"key":"1162_CR23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/intimm\/13.8.993","volume":"13","author":"M Firan","year":"2001","unstructured":"Firan, M. et al. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of \u03b3-globulin in humans. Int. Immunol. 13, 993\u20131002 (2001).","journal-title":"Int. Immunol."},{"key":"1162_CR24","doi-asserted-by":"publisher","first-page":"498.e1","DOI":"10.1016\/j.ajog.2019.02.058","volume":"220","author":"S Roy","year":"2019","unstructured":"Roy, S. et al. M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model. Am. J. Obstet. Gynecol. 220, 498.e1\u2013498.e9 (2019).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1162_CR25","doi-asserted-by":"publisher","first-page":"12943","DOI":"10.1073\/pnas.2004325117","volume":"117","author":"S Borghi","year":"2020","unstructured":"Borghi, S. et al. FcRn, but not Fc\u03b3Rs, drives maternal-fetal transplacental transport of human IgG antibodies. Proc. Natl Acad. Sci. 117, 12943\u201312951 (2020).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1162_CR26","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.4049\/jimmunol.157.8.3317","volume":"157","author":"JL Leach","year":"1996","unstructured":"Leach, J. L. et al. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J. Immunol. 157, 3317\u20133322 (1996).","journal-title":"J. Immunol."},{"key":"1162_CR27","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1002\/eji.1830260718","volume":"26","author":"NE Simister","year":"1996","unstructured":"Simister, N. E., Story, C. M., Chen, H. L. & Hunt, J. S. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur. J. Immunol. 26, 1527\u20131531 (1996).","journal-title":"Eur. J. Immunol."},{"key":"1162_CR28","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/eji.1830260741","volume":"26","author":"EK Kristoffersen","year":"1996","unstructured":"Kristoffersen, E. K. & Matre, R. Co\u2010localization of the neonatal Fc\u03b3 receptor and IgG in human placental term syncytiotrophoblasts. Eur. J. Immunol. 26, 1668\u20131671 (1996).","journal-title":"Eur. J. Immunol."},{"key":"1162_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.placenta.2005.08.008","volume":"27","author":"K Leitner","year":"2006","unstructured":"Leitner, K., Ellinger, I., Grill, M., Brabec, M. & Fuchs, R. Efficient apical IgG recycling and apical-to-basolateral transcytosis in polarized BeWo cells overexpressing hFcRn. Placenta 27, 799\u2013811 (2006).","journal-title":"Placenta"},{"key":"1162_CR30","doi-asserted-by":"publisher","first-page":"11076","DOI":"10.1073\/pnas.0402970101","volume":"101","author":"RJ Ober","year":"2004","unstructured":"Ober, R. J., Martinez, C., Lai, X., Zhou, J. & Ward, E. S. Exocytosis of IgG as mediated by the receptor, FcRn: an analysis at the single-molecule level. Proc. Natl Acad. Sci. 101, 11076\u201311081 (2004).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1162_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0143-4004(91)90506-B","volume":"12","author":"T Kameda","year":"1991","unstructured":"Kameda, T. et al. Localization of three subtypes of Fc\u03b3 receptors in human placenta by immunohistochemical analysis. Placenta 12, 15\u201326 (1991).","journal-title":"Placenta"},{"key":"1162_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.placenta.2019.02.012","volume":"78","author":"T Kiskova","year":"2019","unstructured":"Kiskova, T. et al. Expression of the neonatal Fc-receptor in placental-fetal endothelium and in cells of the placental immune system. Placenta 78, 36\u201343 (2019).","journal-title":"Placenta"},{"key":"1162_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0198-8859(00)00244-5","volume":"62","author":"F Antohe","year":"2001","unstructured":"Antohe, F., R\u0103dulescu, L., Gafencu, A., Ghe\u0163ie, V. & Simionescu, M. Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Hum. Immunol. 62, 93\u2013105 (2001).","journal-title":"Hum. Immunol."},{"key":"1162_CR34","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3389\/fimmu.2020.01920","volume":"11","author":"T Clements","year":"2020","unstructured":"Clements, T. et al. Update on transplacental transfer of IgG subclasses: impact of maternal and fetal factors. Front. Immunol. 11, 1920 (2020).","journal-title":"Front. Immunol."},{"key":"1162_CR35","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/oxfordjournals.humrep.a135906","volume":"10","author":"E Jauniaux","year":"1995","unstructured":"Jauniaux, E. et al. Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy. Hum. Reprod. Oxf. Engl. 10, 3297\u20133300 (1995).","journal-title":"Hum. Reprod. Oxf. Engl."},{"key":"1162_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1600-0897.1996.tb00172.x","volume":"36","author":"A Malek","year":"1996","unstructured":"Malek, A., Sager, R., Kuhn, P., Nicolaides, K. H. & Schneider, H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am. J. Reprod. Immunol. 36, 248\u2013255 (1996).","journal-title":"Am. J. Reprod. Immunol."},{"key":"1162_CR37","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/2101070a0","volume":"210","author":"PF Kohler","year":"1966","unstructured":"Kohler, P. F. & Farr, R. S. Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport. Nature 210, 1070\u20131071 (1966).","journal-title":"Nature"},{"key":"1162_CR38","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/cid\/ciw027","volume":"62","author":"CS Eberhardt","year":"2016","unstructured":"Eberhardt, C. S. et al. Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis. Clin. Infect. Dis. 62, 829\u2013836 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"1162_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/AOG.0000000000004693","volume":"139","author":"YJ Yang","year":"2022","unstructured":"Yang, Y. J. et al. Association of gestational age at coronavirus disease 2019 (COVID-19) vaccination, history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and a vaccine booster dose with maternal and umbilical cord antibody levels at delivery. Obstet. Gynecol. 139, 373\u2013380 (2022).","journal-title":"Obstet. Gynecol."},{"key":"1162_CR40","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1016\/S2666-5247(22)00332-9","volume":"4","author":"A Calvert","year":"2023","unstructured":"Calvert, A. et al. Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trial. Lancet Microbe 4, e300\u2013e308 (2023). This paper reports on a randomized controlled trial that seeks to determine the time in pregnancy at which vaccination maximizes antibody titres in newborns \u2014 at present the only randomized controlled trial to do this.","journal-title":"Lancet Microbe"},{"key":"1162_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/cid\/ciw634","volume":"64","author":"K Winter","year":"2017","unstructured":"Winter, K., Nickell, S., Powell, M. & Harriman, K. Effectiveness of prenatal versus postpartum tetanus, diphtheria, and acellular pertussis vaccination in preventing infant pertussis. Clin. Infect. Dis. 64, 3\u20138 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1162_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2204399","volume":"387","author":"NB Halasa","year":"2022","unstructured":"Halasa, N. B. et al. Maternal vaccination and risk of hospitalization for Covid-19 among infants. N. Engl. J. Med. 387, 109\u2013119 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1162_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-074035","volume":"380","author":"SCJ Jorgensen","year":"2023","unstructured":"Jorgensen, S. C. J. et al. Maternal mRNA Covid-19 vaccination during pregnancy and Delta or Omicron infection or hospital admission in infants: test negative design study. BMJ 380, e074035 (2023).","journal-title":"BMJ"},{"key":"1162_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36547-4","volume":"14","author":"O Zerbo","year":"2023","unstructured":"Zerbo, O. et al. Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life. Nat. Commun. 14, 894 (2023).","journal-title":"Nat. Commun."},{"key":"1162_CR45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.vaccine.2021.12.007","volume":"40","author":"B Oguti","year":"2022","unstructured":"Oguti, B. et al. The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis. Vaccine 40, 450\u2013458 (2022).","journal-title":"Vaccine"},{"key":"1162_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00919271","volume":"13","author":"H Sarvas","year":"1993","unstructured":"Sarvas, H., Sepp\u00e4l\u00e4, I., Kurikka, S., Siegberg, R. & M\u00e4kel\u00e4, O. Half-life of the maternal IgG1 allotype in infants. J. Clin. Immunol. 13, 145\u2013151 (1993).","journal-title":"J. Clin. Immunol."},{"key":"1162_CR47","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.15585\/mmwr.mm7239a3","volume":"72","author":"RM Simeone","year":"2023","unstructured":"Simeone, R. M. Effectiveness of maternal mRNA COVID-19 vaccination during pregnancy against COVID-19\u2013associated hospitalizations in infants aged 6 months during SARS-CoV-2 Omicron predominance \u2014 20 States, March 9, 2022\u2013May 31, 2023. MMWR Morb. Mortal. Wkly. Rep. 72, 1057\u20131064 (2023).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"1162_CR48","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jamapediatrics.2017.0638","volume":"171","author":"M Voysey","year":"2017","unstructured":"Voysey, M. et al. The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses: an individual participant meta-analysis. JAMA Pediatr. 171, 637\u2013646 (2017).","journal-title":"JAMA Pediatr."},{"key":"1162_CR49","first-page":"8","volume":"24","author":"H Akhter","year":"2020","unstructured":"Akhter, H., Aziz, F., Ullah, F. R., Ahsan, M. & Islam, S. N. Immunoglobulins content in colostrum, transitional and mature milk of Bangladeshi mothers: influence of parity and sociodemographic characteristics. J. Mother. Child. 24, 8\u201315 (2020).","journal-title":"J. Mother. Child."},{"key":"1162_CR50","first-page":"6309","volume":"181","author":"O Morteau","year":"2008","unstructured":"Morteau, O. et al. An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J. Immunol. Baltim. Md. 1950 181, 6309\u20136315 (2008).","journal-title":"J. Immunol. Baltim. Md. 1950"},{"key":"1162_CR51","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1084\/jem.20041069","volume":"200","author":"E Wilson","year":"2004","unstructured":"Wilson, E. & Butcher, E. C. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J. Exp. Med. 200, 805\u2013809 (2004).","journal-title":"J. Exp. Med."},{"key":"1162_CR52","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/ni.3213","volume":"16","author":"C Lindner","year":"2015","unstructured":"Lindner, C. et al. Diversification of memory B cells drives the continuous adaptation of secretory antibodies to gut microbiota. Nat. Immunol. 16, 880\u2013888 (2015).","journal-title":"Nat. Immunol."},{"key":"1162_CR53","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.humimm.2003.08.025","volume":"64","author":"P Cianga","year":"2003","unstructured":"Cianga, P., Cianga, C., Cozma, L., Ward, E. S. & Carasevici, E. The MHC class I related Fc receptor, FcRn, is expressed in the epithelial cells of the human mammary gland. Hum. Immunol. 64, 1152\u20131159 (2003).","journal-title":"Hum. Immunol."},{"key":"1162_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070867","volume":"8","author":"EP Schlaudecker","year":"2013","unstructured":"Schlaudecker, E. P. et al. IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization. PLoS ONE 8, e70867 (2013).","journal-title":"PLoS ONE"},{"key":"1162_CR55","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/cid\/cit599","volume":"57","author":"HC Maltezou","year":"2013","unstructured":"Maltezou, H. C. et al. Impact of postpartum influenza vaccination of mothers and household contacts in preventing febrile episodes, influenza-like illness, healthcare seeking, and administration of antibiotics in young infants during the 2012\u20132013 influenza season. Clin. Infect. Dis. 57, 1520\u20131526 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"1162_CR56","doi-asserted-by":"publisher","first-page":"2350090","DOI":"10.1080\/21645515.2024.2350090","volume":"20","author":"MM Oguz","year":"2024","unstructured":"Oguz, M. M. & Senel, S. Effectiveness of cocoon strategy vaccination on prevention of influenza-like illness in young infants. Hum. Vaccines Immunother. 20, 2350090 (2024).","journal-title":"Hum. Vaccines Immunother."},{"key":"1162_CR57","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/cid\/cir836","volume":"54","author":"DM Skowronski","year":"2012","unstructured":"Skowronski, D. M. et al. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin. Infect. Dis. 54, 318\u2013327 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"1162_CR58","unstructured":"Bollinger, O. in \u00dcber Menschen- und Thierpocken, \u00fcber den Ursprung der Kuhpocken und \u00fcber intrauterine Vaccination (Breitkopf & H\u00e4rtel, 1877)."},{"key":"1162_CR59","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/S0140-6736(07)61261-6","volume":"370","author":"MH Roper","year":"2007","unstructured":"Roper, M. H., Vandelaer, J. H. & Gasse, F. L. Maternal and neonatal tetanus. Lancet 370, 1947\u20131959 (2007).","journal-title":"Lancet"},{"key":"1162_CR60","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/bmj.2.5255.785","volume":"2","author":"FD Schofield","year":"1961","unstructured":"Schofield, F. D., Tucker, V. M. & Westbrook, G. R. Neonatal tetanus in new guinea. BMJ 2, 785\u2013789 (1961).","journal-title":"BMJ"},{"key":"1162_CR61","first-page":"863","volume":"35","author":"KW Newell","year":"1966","unstructured":"Newell, K. W., Due\u00f1as Lehmann, A., LeBlanc, D. R. & Garces Osorio, N. The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial. Bull. World Health Organ. 35, 863\u2013871 (1966).","journal-title":"Bull. World Health Organ."},{"key":"1162_CR62","unstructured":"World Health Organization. Maternal and neonatal tetanus elimination (MNTE) (WHO, 2024)."},{"key":"1162_CR63","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/infdis\/132.6.707","volume":"132","author":"PL Kendrick","year":"1975","unstructured":"Kendrick, P. L. Can whooping cough be eradicated? J. Infect. Dis. 132, 707\u2013712 (1975).","journal-title":"J. Infect. Dis."},{"key":"1162_CR64","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S1473-3099(17)30390-0","volume":"17","author":"KHT Yeung","year":"2017","unstructured":"Yeung, K. H. T., Duclos, P., Nelson, E. A. S. & Hutubessy, R. C. W. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect. Dis. 17, 974\u2013980 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"1162_CR65","first-page":"14","volume":"5","author":"LD Frenkel","year":"2018","unstructured":"Frenkel, L. D. Infectious diseases as a cause of global childhood mortality and morbidity: progress in recognition, prevention, and treatment. Adv. Pediatr. Res. 5, 14 (2018).","journal-title":"Adv. Pediatr. Res."},{"key":"1162_CR66","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1001\/jama.1943.02840090026008","volume":"121","author":"P Cohen","year":"1943","unstructured":"Cohen, P. & Scadron, S. J. The placental transmission of protective antibodies against whooping cough: by inoculation of the pregnant mother. J. Am. Med. Assoc. 121, 656 (1943).","journal-title":"J. Am. Med. Assoc."},{"key":"1162_CR67","first-page":"131","volume":"62","author":"M Sawyer","year":"2013","unstructured":"Sawyer, M., Liang, J. L., Messonnier, N. & Clark, T. A. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women \u2014 Advisory Committee on Immunization Practices (ACIP), 2012. Morb. Mortal. Wkly. Rep. 62, 131\u2013135 (2013).","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"1162_CR68","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.vaccine.2023.01.035","volume":"41","author":"NC Grassly","year":"2023","unstructured":"Grassly, N. C. et al. Effect of maternal immunisation with multivalent vaccines containing inactivated poliovirus vaccine (IPV) on infant IPV immune response: a phase 4, multi-centre randomised trial. Vaccine 41, 1299\u20131302 (2023).","journal-title":"Vaccine"},{"key":"1162_CR69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/cid\/ciz778","volume":"71","author":"N Wanlapakorn","year":"2020","unstructured":"Wanlapakorn, N. et al. Quantity and quality of antibodies after acellular versus whole-cell pertussis vaccines in infants born to mothers who received tetanus, diphtheria, and acellular pertussis vaccine during pregnancy: a randomized trial. Clin. Infect. Dis. 71, 72\u201380 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"1162_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44943-7","volume":"15","author":"M Briga","year":"2024","unstructured":"Briga, M., Goult, E., Brett, T. S., Rohani, P. & Domenech de Cell\u00e8s, M. Maternal pertussis immunization and the blunting of routine vaccine effectiveness: a meta-analysis and modeling study. Nat. Commun. 15, 921 (2024).","journal-title":"Nat. Commun."},{"key":"1162_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/752852","volume":"2013","author":"E Sappenfield","year":"2013","unstructured":"Sappenfield, E., Jamieson, D. J. & Kourtis, A. P. Pregnancy and susceptibility to infectious diseases. Infect. Dis. Obstet. Gynecol. 2013, 1\u20138 (2013).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"1162_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000441","volume":"8","author":"SB Omer","year":"2011","unstructured":"Omer, S. B. et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLOS Med. 8, e1000441 (2011).","journal-title":"PLOS Med."},{"key":"1162_CR73","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1001\/archpediatrics.2010.192","volume":"165","author":"AA Eick","year":"2011","unstructured":"Eick, A. A. et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch. Pediatr. Adolesc. Med. 165, 104\u2013111 (2011).","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"1162_CR74","doi-asserted-by":"publisher","first-page":"20959","DOI":"10.2807\/1560-7917.ES2014.19.45.20959","volume":"19","author":"G Dabrera","year":"2014","unstructured":"Dabrera, G. et al. Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013\/14. Eurosurveillance 19, 20959 (2014).","journal-title":"Eurosurveillance"},{"key":"1162_CR75","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1086\/657309","volume":"51","author":"I Benowitz","year":"2010","unstructured":"Benowitz, I., Esposito, D. B., Gracey, K. D., Shapiro, E. D. & V\u00e1zquez, M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin. Infect. Dis. 51, 1355\u20131361 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"1162_CR76","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1016\/j.ajog.2011.02.042","volume":"204","author":"KA Poehling","year":"2011","unstructured":"Poehling, K. A. et al. Impact of maternal immunization on influenza hospitalizations in infants. Am. J. Obstet. Gynecol. 204, S141\u2013S148 (2011).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1162_CR77","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jamainternmed.2022.2442","volume":"182","author":"E\u00d8 Carlsen","year":"2022","unstructured":"Carlsen, E. \u00d8. et al. Association of COVID-19 vaccination during pregnancy with incidence of SARS-CoV-2 infection in infants. JAMA Intern. Med. 182, 825\u2013831 (2022).","journal-title":"JAMA Intern. Med."},{"key":"1162_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34605-x","volume":"13","author":"J Guedalia","year":"2022","unstructured":"Guedalia, J. et al. Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel. Nat. Commun. 13, 6961 (2022).","journal-title":"Nat. Commun."},{"key":"1162_CR79","doi-asserted-by":"publisher","first-page":"264","DOI":"10.15585\/mmwr.mm7107e3","volume":"71","author":"NB Halasa","year":"2022","unstructured":"Halasa, N. B. et al. Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-associated hospitalization in infants aged <6 months \u2014 17 States, July 2021\u2013January 2022. MMWR Morb. Mortal. Wkly. Rep. 71, 264\u2013270 (2022).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"1162_CR80","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jpeds.2022.09.059","volume":"254","author":"D Danino","year":"2023","unstructured":"Danino, D. et al. Effectiveness of BNT162b2 vaccination during pregnancy in preventing hospitalization for severe acute respiratory syndrome coronavirus 2 in infants. J. Pediatr. 254, 48\u201353.e1 (2023).","journal-title":"J. Pediatr."},{"key":"1162_CR81","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073639","volume":"382","author":"H Wilde","year":"2023","unstructured":"Wilde, H. et al. Hospital admissions linked to SARS-CoV-2 infection in children and adolescents: cohort study of 3.2 million first ascertained infections in England. BMJ 382, e073639 (2023).","journal-title":"BMJ"},{"key":"1162_CR82","doi-asserted-by":"publisher","first-page":"830","DOI":"10.15585\/mmwr.mm7338a1","volume":"73","author":"FP Havers","year":"2024","unstructured":"Havers, F. P. COVID-19\u2013associated hospitalizations and maternal vaccination among infants aged 6 months \u2014 COVID-NET, 12 States, October 2022\u2013April 2024. MMWR Morb. Mortal. Wkly. Rep. 73, 830\u2013836 (2024).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"1162_CR83","unstructured":"Centers for Disease Control and Prevention. Flu vaccine safety and pregnancy (CDC, 2025)."},{"key":"1162_CR84","unstructured":"Australian Government Department of Health and Aged Care. Therapeutic Goods Administration public summary VAXIGRIP TETRA inactivated quadrivalent influenza vaccine (split virion) influenza virus HA 60\u2009mcg 0.5\u2009mL suspension for injection PFS needle free (ARTG, 2025)."},{"key":"1162_CR85","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJM197504102921503","volume":"292","author":"CE Stevens","year":"1975","unstructured":"Stevens, C. E., Beasley, R. P., Tsui, J. & Lee, W.-C. Vertical transmission of hepatitis B antigen in Taiwan. N. Engl. J. Med. 292, 771\u2013774 (1975).","journal-title":"N. Engl. J. Med."},{"key":"1162_CR86","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1001\/jama.1985.03350360066020","volume":"253","author":"CE Stevens","year":"1985","unstructured":"Stevens, C. E. et al. Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA 253, 1740\u20131745 (1985).","journal-title":"JAMA"},{"key":"1162_CR87","unstructured":"World Health Organization. Global hepatitis report (WHO, 2017)."},{"key":"1162_CR88","first-page":"CD008545","volume":"2","author":"AC Eke","year":"2010","unstructured":"Eke, A. C., Eke, U. A. & Uchenna, E. Hepatitis B immunoglobulin during pregnancy for the prevention of mother to child transmission of hepatitis B virus. Cochrane Database Syst. Rev. 2, CD008545 (2010).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1162_CR89","first-page":"CD004790","volume":"19","author":"C Lee","year":"2006","unstructured":"Lee, C., Gong, Y., Brok, J., Boxall, E. H. & Gluud, C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst. Rev. 19, CD004790 (2006).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1162_CR90","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/00006454-200111000-00009","volume":"20","author":"E Lewis","year":"2001","unstructured":"Lewis, E. et al. Safety of neonatal hepatitis B vaccine administration. Pediatr. Infect. Dis. J. 20, 1049\u20131054 (2001).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1162_CR91","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/01.inf.0000130953.08946.d0","volume":"23","author":"EM Eriksen","year":"2004","unstructured":"Eriksen, E. M. et al. Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project. Pediatr. Infect. Dis. J. 23, 656\u2013662 (2004).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1162_CR92","unstructured":"World Health Organization. Which countries include hepatitis B birth dose vaccines in their vaccination schedules? [dataset] (Our World in Data, 2024)."},{"key":"1162_CR93","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7326\/0003-4819-107-2-335","volume":"107","author":"MM Jonas","year":"1987","unstructured":"Jonas, M. M. et al. Failure of Centers for Disease Control criteria to identify hepatitis B infection in a large municipal obstetrical population. Ann. Intern. Med. 107, 335\u2013337 (1987).","journal-title":"Ann. Intern. Med."},{"key":"1162_CR94","doi-asserted-by":"publisher","first-page":"273","DOI":"10.7326\/0003-4819-107-2-273","volume":"107","author":"ML Kumar","year":"1987","unstructured":"Kumar, M. L. et al. Should all pregnant women be screened for hepatitis B? Ann. Intern. Med. 107, 273\u2013277 (1987).","journal-title":"Ann. Intern. Med."},{"key":"1162_CR95","unstructured":"World Health Organization. Polio vaccines: WHO position paper \u2014 June 2022 (WHO, 2022)."},{"key":"1162_CR96","doi-asserted-by":"crossref","unstructured":"World Health Organization. BCG vaccines: WHO position paper \u2014 February 2018 \u2014 Vaccins BCG: Note de synth\u00e8se de l\u2019OMS \u2014 F\u00e9vrier 2018 (WHO, 2018).","DOI":"10.1016\/j.vaccine.2018.03.009"},{"key":"1162_CR97","doi-asserted-by":"publisher","first-page":"e1307","DOI":"10.1016\/S2214-109X(22)00283-2","volume":"10","author":"L Martinez","year":"2022","unstructured":"Martinez, L. et al. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. Lancet Glob. Health 10, e1307\u2013e1316 (2022).","journal-title":"Lancet Glob. Health"},{"key":"1162_CR98","first-page":"853","volume":"64","author":"DX Dong","year":"1986","unstructured":"Dong, D. X. et al. Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin). Bull. World Health Organ. 64, 853\u2013860 (1986).","journal-title":"Bull. World Health Organ."},{"key":"1162_CR99","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/tropej\/43.4.232","volume":"43","author":"P Bhaskaram","year":"1997","unstructured":"Bhaskaram, P., Nair, K. M., Hemalatha, P., Murthy, N. & Nair, P. Systemic and mucosal immune response to polio vaccination with additional dose in newborn period. J. Trop. Pediatr. 43, 232\u2013234 (1997).","journal-title":"J. Trop. Pediatr."},{"key":"1162_CR100","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1016\/j.vaccine.2011.04.133","volume":"29","author":"TJ John","year":"2011","unstructured":"John, T. J. et al. Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials. Vaccine 29, 5793\u20135801 (2011).","journal-title":"Vaccine"},{"key":"1162_CR101","unstructured":"UK Health Security Agency. Vaccine update: issue 327, April 2022, SCID, TB and BCG special edition (UKHSA, 2022)."},{"key":"1162_CR102","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet Lond. Engl. 399, 2047\u20132064 (2022).","journal-title":"Lancet Lond. Engl."},{"key":"1162_CR103","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062574","volume":"153","author":"AT Curns","year":"2024","unstructured":"Curns, A. T. et al. Respiratory syncytial virus-associated hospitalizations among children <5 years old: 2016 to 2020. Pediatrics 153, e2023062574 (2024).","journal-title":"Pediatrics"},{"key":"1162_CR104","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1093\/infdis\/jiac120","volume":"226","author":"M Suh","year":"2022","unstructured":"Suh, M. et al. Respiratory syncytial virus is the leading cause of united states infant hospitalizations, 2009\u20132019: a study of the national (Nationwide) inpatient sample. J. Infect. Dis. 226, S154\u2013S163 (2022).","journal-title":"J. Infect. Dis."},{"key":"1162_CR105","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1056\/NEJMoa0804877","volume":"360","author":"CB Hall","year":"2009","unstructured":"Hall, C. B. et al. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360, 588\u2013598 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1162_CR106","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(24)00138-7","volume":"403","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data. Lancet Lond. Engl. 403, 1241\u20131253 (2024).","journal-title":"Lancet Lond. Engl."},{"key":"1162_CR107","unstructured":"World Health Organization. RSV vaccine research and development technology roadmap: priority activities for development, testing, licensure and global use of RSV vaccines, with a specific focus on the medical need for young children in low- and middle-income countries (WHO, 2017)."},{"key":"1162_CR108","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa2305478","volume":"390","author":"I Dieussaert","year":"2024","unstructured":"Dieussaert, I. et al. RSV prefusion F protein\u2013based maternal vaccine \u2014 preterm birth and other outcomes. N. Engl. J. Med. 390, 1009\u20131021 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1162_CR109","unstructured":"Moro, P. Maternal RSV vaccine safety surveillance (CDC, 2024)."},{"key":"1162_CR110","unstructured":"Food and Drug Administration & Center for Biologics Evaluation and Research. 181st Meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) (FDA, 2023)."},{"key":"1162_CR111","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJMoa2110275","volume":"386","author":"LL Hammitt","year":"2022","unstructured":"Hammitt, L. L. et al. Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N. Engl. J. Med. 386, 837\u2013846 (2022). This paper reports on the pivotal randomized controlled trial that demonstrated the benefit of nirsevimab in preventing RSV in healthy infants born at or near term.","journal-title":"N. Engl. J. Med."},{"key":"1162_CR112","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1913556","volume":"383","author":"MP Griffin","year":"2020","unstructured":"Griffin, M. P. et al. Single-dose nirsevimab for prevention of RSV in preterm infants. N. Engl. J. Med. 383, 415\u2013425 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1162_CR113","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","volume":"389","author":"SB Drysdale","year":"2023","unstructured":"Drysdale, S. B. et al. Nirsevimab for prevention of hospitalizations due to RSV in infants. N. Engl. J. Med. 389, 2425\u20132435 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1162_CR114","first-page":"2400046","volume":"29","author":"M L\u00f3pez-Lacort","year":"2024","unstructured":"L\u00f3pez-Lacort, M. et al. Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024. Eur. Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull. 29, 2400046 (2024).","journal-title":"Eur. Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull."},{"key":"1162_CR115","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S1473-3099(24)00215-9","volume":"24","author":"S Ares-G\u00f3mez","year":"2024","unstructured":"Ares-G\u00f3mez, S. et al. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study. Lancet Infect. Dis. 24, 817\u2013828 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1162_CR116","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S2352-4642(24)00143-3","volume":"8","author":"A Brault","year":"2024","unstructured":"Brault, A. et al. Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023\u201324: a modelling study. Lancet Child Adolesc. Health 8, 721\u2013729 (2024).","journal-title":"Lancet Child Adolesc. Health"},{"key":"1162_CR117","first-page":"2400033","volume":"29","author":"C Ernst","year":"2024","unstructured":"Ernst, C. et al. Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023\/24 season in Luxembourg. Eur. Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull. 29, 2400033 (2024).","journal-title":"Eur. Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull."},{"key":"1162_CR118","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13311","volume":"18","author":"J Paireau","year":"2024","unstructured":"Paireau, J. et al. Nirsevimab effectiveness against cases of respiratory syncytial virus bronchiolitis hospitalised in paediatric intensive care units in France, September 2023\u2013January 2024. Influenza Other Respir. Viruses 18, e13311 (2024).","journal-title":"Influenza Other Respir. Viruses"},{"key":"1162_CR119","doi-asserted-by":"publisher","first-page":"209","DOI":"10.15585\/mmwr.mm7309a4","volume":"73","author":"HL Moline","year":"2024","unstructured":"Moline, H. L. et al. Early estimate of nirsevimab effectiveness for prevention of respiratory syncytial virus-associated hospitalization among infants entering their first respiratory syncytial virus season \u2014 new vaccine surveillance network, October 2023\u2013February 2024. MMWR Morb. Mortal. Wkly. Rep. 73, 209\u2013214 (2024).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"1162_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12137-1","volume":"10","author":"A Tang","year":"2019","unstructured":"Tang, A. et al. A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein. Nat. Commun. 10, 4153 (2019).","journal-title":"Nat. Commun."},{"key":"1162_CR121","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.q2852","volume":"387","author":"E Mahase","year":"2024","unstructured":"Mahase, E. FDA pauses all infant RSV vaccine trials after rise in severe illnesses. BMJ 387, q2852 (2024).","journal-title":"BMJ"},{"key":"1162_CR122","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1093\/cid\/cix664","volume":"65","author":"AC Seale","year":"2017","unstructured":"Seale, A. C. et al. Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin. Infect. Dis. 65, S200\u2013S219 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1162_CR123","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","volume":"10","author":"BP Gon\u00e7alves","year":"2022","unstructured":"Gon\u00e7alves, B. P. et al. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob. Health 10, e807\u2013e819 (2022).","journal-title":"Lancet Glob. Health"},{"key":"1162_CR124","doi-asserted-by":"publisher","first-page":"754013","DOI":"10.3389\/fped.2021.754013","volume":"9","author":"S Prescott","year":"2021","unstructured":"Prescott, S. et al. Impact of intrapartum antibiotic prophylaxis on offspring microbiota. Front. Pediatr. 9, 754013 (2021).","journal-title":"Front. Pediatr."},{"key":"1162_CR125","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJM197604012941404","volume":"294","author":"CJ Baker","year":"1976","unstructured":"Baker, C. J. & Kasper, D. L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N. Engl. J. Med. 294, 753\u2013756 (1976).","journal-title":"N. Engl. J. Med."},{"key":"1162_CR126","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/infdis\/jiz062","volume":"220","author":"ET Buurman","year":"2019","unstructured":"Buurman, E. T. et al. A novel hexavalent capsular polysaccharide conjugate vaccine (GBS6) for the prevention of neonatal group b streptococcal infections by maternal immunization. J. Infect. Dis. 220, 105\u2013115 (2019).","journal-title":"J. Infect. Dis."},{"key":"1162_CR127","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1473-3099(20)30478-3","volume":"21","author":"J Absalon","year":"2021","unstructured":"Absalon, J. et al. Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1\/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial. Lancet Infect. Dis. 21, 263\u2013274 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1162_CR128","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa2116045","volume":"389","author":"SA Madhi","year":"2023","unstructured":"Madhi, S. A. et al. Potential for maternally administered vaccine for infant group B streptococcus. N. Engl. J. Med. 389, 215\u2013227 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1162_CR129","unstructured":"Minist\u00e8re du Travail, de la Sant\u00e9, et des Solidarit\u00e9s. Beyfortus (nirsevimab): priorisation temporaire des patients \u00e0 immuniser (Minist\u00e8re du Travail, 2023)."},{"key":"1162_CR130","unstructured":"Centers for Disease Control. Limited availability of nirsevimab in the United States \u2014 Iinterim CDC recommendations to protect infants from respiratory syncytial virus (RSV) during the 2023\u20132024 respiratory virus season (CDC, 2023)"},{"key":"1162_CR131","unstructured":"UK Health and Security Agency. Vaccine update: issue 344, November 2023, pregnancy special (UKHSA, 2023)."},{"key":"1162_CR132","unstructured":"UK Health Security Agency. In Influenza: the Green Book Ch.19 (UKHSA, 2023)."},{"key":"1162_CR133","unstructured":"UK Health Security Agency. In Pertussis: the Green Book Ch. 24 (UKHSA, 2024)."},{"key":"1162_CR134","unstructured":"UK Health Security Agency. In Respiratory Syncytial Virus: the Green Book Ch. 27a (UKHSA, 2024)."},{"key":"1162_CR135","unstructured":"Department of Health & Social Care. JCVI statement on COVID-19 vaccination in 2025 and spring 2026 (DHSC, 2024)."},{"key":"1162_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-12198-2","volume":"21","author":"T Ba\u00efssas","year":"2021","unstructured":"Ba\u00efssas, T. et al. Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain. BMC Public. Health 21, 2182 (2021).","journal-title":"BMC Public. Health"},{"key":"1162_CR137","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1016\/j.vaccine.2023.05.047","volume":"41","author":"SL Mitchell","year":"2023","unstructured":"Mitchell, S. L., Schulkin, J. & Power, M. L. Vaccine hesitancy in pregnant Women: a narrative review. Vaccine 41, 4220\u20134227 (2023).","journal-title":"Vaccine"},{"key":"1162_CR138","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.1016\/j.vaccine.2017.10.049","volume":"36","author":"A Gagneur","year":"2018","unstructured":"Gagneur, A., Gosselin, V. & Dub\u00e9, \u00c8. Motivational interviewing: a promising tool to address vaccine hesitancy. Vaccine 36, 6553\u20136555 (2018).","journal-title":"Vaccine"},{"key":"1162_CR139","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev-virology-100220-010653","volume":"9","author":"X Hu","year":"2022","unstructured":"Hu, X., Wang, H.-Y., Otero, C. E., Jenks, J. A. & Permar, S. R. Lessons from acquired natural immunity and clinical trials to inform next-generation human cytomegalovirus vaccine development. Annu. Rev. Virol. 9, 491\u2013520 (2022).","journal-title":"Annu. Rev. Virol."},{"key":"1162_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-024-00889-x","volume":"9","author":"SE Woodson","year":"2024","unstructured":"Woodson, S. E. & Morabito, K. M. Continuing development of vaccines and monoclonal antibodies against Zika virus. Npj Vaccines 9, 1\u20138 (2024).","journal-title":"Npj Vaccines"},{"key":"1162_CR141","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/trstmh\/traa011","volume":"114","author":"ND Kayem","year":"2020","unstructured":"Kayem, N. D. et al. Lassa fever in pregnancy: a systematic review and meta-analysis. Trans. R. Soc. Trop. Med. Hyg. 114, 385\u2013396 (2020).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"1162_CR142","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7326\/0003-4819-147-1-200707030-00005","volume":"147","author":"S Patra","year":"2007","unstructured":"Patra, S., Kumar, A., Trivedi, S. S., Puri, M. & Sarin, S. K. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann. Intern. Med. 147, 28\u201333 (2007).","journal-title":"Ann. Intern. Med."},{"key":"1162_CR143","unstructured":"World Health Organization. Hepatitis E vaccine: WHO position paper, May 2015 (WHO, 2015)."},{"key":"1162_CR144","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(23)02234-1","volume":"403","author":"S Huang","year":"2024","unstructured":"Huang, S. et al. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Lond. Engl. 403, 813\u2013823 (2024).","journal-title":"Lancet Lond. Engl."}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41577-025-01162-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-025-01162-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-025-01162-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:34:15Z","timestamp":1757169255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-025-01162-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":144,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1162"],"URL":"https:\/\/doi.org\/10.1038\/s41577-025-01162-5","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"13 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.J. carries out clinical trials on behalf of her institution, sponsored by vaccine manufacturers, but receives no personal payment for this work; she is a member of the Joint Committee of Vaccination and Immunization RSV subcommittee. V.M. has no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}